The subject of organ regeneration has attracted substantial investigative attention and has been extensively reviewed. Therefore, I shall focus on several only recently emerged issues and on those aspects of stem cell-mediated regeneration which, although are important in my opinion, have nevertheless evaded the radar of scientific pursuit. Specifically, I shall describe the recent work on the prominence of local lineage-restricted stem cells, as opposed to the bone marrow-derived or circulating ones, in regeneration. This will be followed by an attempt to re-interpret a bulk of published data on the beneficial effects of cell therapy with the focus on the secretome of stem cells. Multiple factors that conspire to cause insufficient or failed regeneration in adult mammals will be screened with emphasis placed on the mechanical forces, senescence and exhaustion, each leading to phenotypical switch and/or stem cell incompetence. Finally, I shall enumerate several potential pathways to induce or restore stem cell competence. Although a significant amount of work has been performed in the nonrenal field, I would hope that some of the mechanisms and concepts discussed herein will eventually trickle into kidney regeneration.
The relative youth of the subject of organ regeneration in general and renal in particular contrasts well with the high level of sophistication employed in research into the subject and the attention it receives. Many aspects of renal stem cells and kidney regeneration have been extensively reviewed. For this reason, and due to space limitations, only a few 'cherrypicked' topics, which have emerged very recently or have not received sufficient attention in the past, will be discussed herein. For others, the interested reader is referred to excellent recent reviews and expanded references therein [1] [2] [3] [4] [5] [6] [7] .
Diverse stem cells, such as bone marrow-derived stem cells, mesenchymal stem cells (MSCs), 'side-population' cells and endothelial progenitor cells (EPCs), are present in the kidney and have been used to improve the regeneration of injured kidneys. Recent studies implicated organ-specific, renal stem cells in the regeneration of adult kidney. Development of functional incompetence and/or exhaustion of their pool in the course of disease carries the blame for insufficient intrinsic capacity to regenerate the injured organ [8, 9] . Pa r t i c i p at i o n o f l o c a l st e m c e l l s i n re g e n e rat i o n Organ regeneration in adult mammals is limited. Using a unique model of digit-tip amputation in mice, Rinkevich et al. [10] explored three scenarios aimed to explain digit regeneration: (i) contribution of circulating precursors, (ii) dedifferentiation of mature local cells to form a pluripotent blastema and (iii) involvement of tissue-specific (ectodermal, mesodermal and endothelial) stem cells that are responsible for embryonic development, but after amputation could lead the restitution. Genetic fate mapping and lineage tracing combined with genetically distinct pairs of parabiotic mice provided solid evidence in favor of the third scenario: local lineage-restricted stem cells are responsible for regeneration. These ground-breaking findings were echoed in studies by Salven's group [11] , which showed that blood vessel wall is endowed with rare c-kit+ endothelial stem cells that can be clonally expanded and are indispensable for angiogenesis. Collectively, these investigations seriously challenge the existing paradigm that ascribes to bone marrow-mobilized or circulating stem cells the role of primary effectors of regeneration. In addition, these studies predict the existence of diverse populations of lineage-restricted local stem/progenitor cells in different organs as major drivers of regeneration.
There is growing awareness of the fact that organ regeneration depends on angiogenesis. Rafii's group [12] investigated the mechanisms responsible for regenerative lung alveolarization and specifically the role of angiocrine factors-molecular cues essential for tissue regeneration that are released by angiogenic endothelial cells. One of such cues was identified as a VEGF-dependent up-regulation on endothelial cells of the membrane-type 1 matrix metalloproteinase, MMP-14, which cleaves the γ2 chain of laminin 5 to generate EGF-like fragments activating epithelial EGF receptor and alveolar regeneration. Similarly, endothelial progenitors have been shown to support the regeneration of liver parenchyma after partial hepatectomy [13] . These and other studies allow us to put forward a concept of angiogenesis-driven regeneration processes, as cartooned in Figure 1 . A similar concept has recently been proposed for kidney regeneration [14] .
Mechanisms of indirect effects of stem cell transplantation With the limited engraftment efficiency (<1-2%) of circulating or transplanted stem cells, on the one hand, and existing substantial literature on beneficial effects of stem cell transplantation, on the other, it has become imperative to understand indirect mechanisms responsible for improved organ (renal) function after cell therapy. Some of the proposed mechanisms (rejuvenation and cell repair by microvesicles and tunneling nanotubes) have recently been reviewed [15, 16] . I shall focus on the secretome of stem cells.
Secretome of stem cells. Evidence that conditioned medium mimics the effect of stem cells is accruing. Cantley's group demonstrated that MSC-conditioned medium ameliorates acute kidney injury [17] . In a rat model of fulminant hepatic failure, Parekkadan et al. [18] applied two distinct strategies to deliver secretory products of MSC: a bolus intravenous injection of conditioned medium and an extracorporeal perfusion of a bioreactor containing MSC. Investigators reported a cell mass-dependent reduction in mortality and cooling down of inflammatory infiltration of the liver. The above effect could not be reproduced when the conditioned medium was initially passed through a heparin-binding column that removes all chemokines, but the effect of conditioned medium was retained in the heparin-bound eluted fraction. Yet another delivery tool, self-assembled peptide nanofibers preconditioned with embryonic stem cell secretome, proved to be renoprotective in a model of LPS-induced kidney injury [19] . Verhaar's group used MSC-conditioned medium to repeatedly inject rats with 5/6 nephrectomy and nitric oxide synthase inhibitorinduced chronic kidney injury [20] . Investigators showed that this therapy halted the progression of nephrosclerosis and reduced hypertension and glomerular injury; the effects that were found to be unrelated to the MSC-derived exosomes.
The ways secretome can affect cell behavior are astonishing. Cardiomyocytes maintained in a regular culture medium actively contract for 6 days, but when they are cultured in the medium conditioned by cardiac fibroblasts, this ability to contract is rapidly lost [21] . The fibroblast-conditioned medium was found to contain higher levels of VEGF, GRO/KC, MCP-1, leptin, MIP-1α, IL-6, IL-10, IL-12p70, IL-17, TNFα, latent TGF-β and RANTES, thus leaving unresolved the question of causality of the phenotype change to any of the above cytokines or their combinations.
Attempts to reveal the composition of stem cell secretome using in vitro-conditioned cell culture medium are at early stages. The problem of eliminating serum in the culture media to allow for a sufficiently sensitive analyses poses biological problems like reduced cell survival and potential changes in the secretome, whereas different investigative tools, such as mass spectrometry (MS) ( poor sensitivity for molecules at low concentrations of 10-20 fmol) and antibody-based techniques (ELISA and antibody arrays; sensitivity 1-10 pg/mL), yield only partially overlapping or even non-overlapping results, emphasizing existing technical limitations. By combining both platforms, Sze et al. [22] identified 201 unique proteins; of which, 132 were disclosed using liquid chromatography-MS/ MS and 72 using antibody arrays. Only three proteins (IGFBP-2, tissue metalloproteinase inhibitors TIMP1 and TIMP2) were identified by both techniques. Profiling of cytokine secretion by MSC [23] revealed high levels of IL-6, IL-8, TIMP-2, VEGF and MCP-1, in addition to various growth factors, extracellular matrix proteases, hormones and lipid mediators [24] . A recent review by Skalnikova et al. [25] provides an up-to-date broad view on the secretome of various types of stem cells. High-resolution MS analysis of the secretome of EPCs cultured for 3 days in a serum-free medium yielded 133 proteins, some known as membrane-bound, and others as secreted [26] . For instance, soluble forms of all three VEGF receptors, adhesion molecules, semaphorin 3F and transforming growth factor-β, CD109, members of roundabout (robo) family, as well as endothelial markers. Pula et al. 
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were MMP-9, IL-8, MIF, various cathepsins and protease inhibitors, S100 proteins A11, A8 and A4, PAI-2 and apolipoprotein E, as well as a potent pro-angiogenic and pro-survival factor thymidine phosphorylase. Thymidine phosphorylase also increased the number and dimensions of focal adhesions in mature endothelial cells and stimulated their migration and wound healing. All these preclinical investigations underpinned the shift from 'cell therapy' to 'cell-free therapy' (rev in: [24] ) that has already resulted in several successful and on-going clinical trials, conducted mostly in patients with cardiovascular disease.
Sheddome, a portion of the secretome that is represented by non-secretory proteins which appear in the conditioned medium as a result of epitope shedding, is another poorly investigated subject. Shedding of syndecans, type 1 transmembrane heparin sulfate proteoglycans, is executed by several different sheddases belonging to the family of metzincins and mediated by growth factors, chemokines, conditions leading to cell stress and during wound healing (rev. in [28] ). Shedding of syndecan 1 is essential for the resolution of inflammation. Soluble endoglin (CD105), a cleavage product of a transmembrane co-receptor for TGF-β, which can inhibit angiogenesis, may contribute to preeclampsia. Among many other members of sheddome are the sonic hedgehog and monocyte-macrophase-specific scavenger receptor CD163, each contributing to regenerative processes. This potentially important field awaits exploration.
Potential causes of regenerative failure: induction of stem cell incompetence
In the course of various diseases, including acute and chronic kidney disease, multiple factors conspire to cause insufficient or failed regeneration substituting it with tissue scarring. Noxious stimuli, known to affect renal parenchymal cells, damage stem cells as well, thus interfering with their regenerative capability [29] . DNA damage response is one of the main culprits in stem cell demise. For instance, in Fanconi anemia, an inherited DNA repair deficiency syndrome, the exaggerated p53 DNA damage response in hematopoietic stem cells triggers p21-mediated cell cycle arrest and bone marrow failure [30] . MSC are vulnerable to chemotherapeutic stress, but less affected by the ionizing radiation. In contrast, embryonic stem cells are extremely sensitive to irradiation. There is growing awareness of the role of epigenetic modifications of histones and micro-RNA contribution to the regulation of stem cell quiescence and differentiation, but these broad areas of studies are beyond the scope of this brief review. Incompetence of EPCs in the presence of metabolic syndrome has been documented [31] .
Premature senescence or exhaustion of stem cells. Stressinduced premature senescence (SIPS) of endothelial cells has emerged as an ominous contributor to global endothelial cell dysfunction and vasculopathy in aging and diseases as diverse as diabetes, hypertension, chronic kidney disease and atherosclerosis. One of the critical cellular abnormalities mechanistically linked to SIPS is lysosomal dysfunction. We examined the impact of a range of relevant cardiovascular risk factors on the expression of SIRT1, SIPS and apoptosis and documented the role of SIRT1 in the changes of EPC viability [32] . Furthermore, studies showed reciprocal relations between SIRT1 and p62/SQSTM-1 expression in stressed EPC, thus demonstrating an attendant abnormality of autophagy. The described effects of stressors could be partially mimicked by inducing lysosomal membrane permeabilization or inhibiting autophagy and the effect of stressors could be reversed by a cell-permeable inhibitor of cathepsins. In vitro studies demonstrated that SIRT1 is a substrate of cysteine cathepsins B, S and L. An antioxidant/peroxynitrite scavenger, ebselen, shown in the previous studies to protect endothelial cells and EPC from SIPS, prevented stress-induced SIRT1 depletion and subversion of autophagy by mitigating lysosomal dysfunction. These data advanced the concept of 'stem cell aging' by establishing the critical role of lysosomal dysfunction in the development of SIPS through the cathepsin-induced depletion of SIRT1, a hitherto hidden mechanism linking cell stress with apoptosis or SIPS, as schematically illustrated in Figure 2 .
To further investigate the contribution of endothelial SIRT1 deficiency to SIPS and vasculopathy, we used cre-lox strategy to generate mice with truncated SIRT1 gene in Tie-2-expressing endothelial (EC) and EPCs. Endo-SIRT1(−/−) mice exhibit mild suppression of acetylcholine-induced vasorelaxation and ex vivo angiogenesis, elevated numbers of senescent EC and EPC, as well as interstitial fibrosis, but no proteinuria or elevation of serum creatinine. When challenged with folic acid, mice develop an exaggerated acute loss of function compared with heterozygote or wild-type controls. Three months later, Endo-SIRT1(−/−) mice develop proteinuria and renal insufficiency and the degree of tubulointerstitial fibrosis which were much enhanced compared with controls. Expression of a master regulator of matrix metalloproteases, MMP-14, was down-regulated. Pharmacologic induction of MMP-14 expression in mice with chronic SIRT1 inhibition reduced tubulointerstitial scarring and proteinuria. Data obtained in Endo-SIRT1(−/−) mice demonstrate the pathogenetic link between SIRT1 expression, SIPS and fibrotic transformation that is a result of the MMP-14 deficiency (unpublished data).
Additional factors perturbing stem cell fate and leading to exhaustion of their pool include persistent activation of Wnt pathway through activation of mTOR [33] . In fact, this mechanism justifies therapeutic trials of mTOR inhibition with rapamycin in an attempt to halt senescence and/or exhaustion of stem cells. Notch signaling by non-diffusible, membranebound ligands expressed on adjacent cells appears to be a prerequisite for asymmetric cell division and differentiation of some stem cells [34] . Yes-associated protein (YAP) is another factor responsive to the stiffness of ECM and Rho GTPases, which controls epithelial stem cell compound by regulating its renewal and differentiation (rev. in [33] ).
Mechanome and stem cell incompetence. Cell tensegrity, the balance of mechanical forces acting on it from the extracellular matrix (outside-in signaling) or from the stress fibers and focal adhesions (inside-out signaling) are wellknown modifiers of cell phenotype [35] . Reprogramming of stem cells can be achieved through changes in their tensegrity. MSC cultured on the polymeric substrates with differently microfabricated topography, even in the absence of differentiating media, promoted either enhanced cell adhesion without differentiation (10 nm depth) or osteoblastic reprogramming on deeper substrate grooves (100 nm) [36] . Song et al. [37] measured stem cell surface strain and correlated it with transcription of genes characteristic of lineage commitment. Findings showed significant correlation between live stem cell stress-strain relations and lineage commitment. Subjecting embryonic stem cells to laminar shear stress 1.5-15 dyne/cm 2 promoted endothelial and hematopoietic differentiation, which was inhibited by the blockade of Flk receptor for VEGF [38] . Comparative analysis of transcriptional responses to shear stress of endothelial colony-forming cells (ECFC) and mature endothelial cells showed that, although they differ under static conditions, shear stress (0.5-2.5 Pa) applied to ECFC lead to expression of differentiation markers similar to those of mature endothelial cells [39] .
On this background, the possibility that tissue injury may cause changes in the mechanome of stem cells has been investigated. Measurements of mechanical properties of fibrotic tissues showed that they are several-fold more rigid than normal tissues (rev. in: [40] ). These rigid areas attract much stronger than soft substrates different types of cells to adhere and spread in a process termed 'durotaxis'. Spreading and tight adhesion result in contraction of the matrix, the process which depends on the expression of non-muscle myosin, integrins and Rac/Rho participation. In accordance with this, inhibition of Rho kinase effector, ROCK, which inactivates myosin, eliminates cell differentiating effects of rigid substrates. Conversion of fibroblasts to myofibroblasts depends on convergence of two signals: one coming from the elevated levels of TGF-β and the other from the stiff matrix with E>20 kPa. In fact, release of TGF-β normally sequestered by the extracellular matrix is mediated by contraction-induced unfolding of ECM proteins. Similar mechanical forces unfold the Notch receptor, thus opening the cleavage site and eventually releasing the nucleus-targeting fragment. As mentioned above, stiff matrices promote cell fate programs distinct from those promoted by soft matrices. In MSC, rigid surfaces induce osteogenic differentiation, while surfaces mimicking the elasticity of muscle induce myogenic differentiation. Similarly, neuronal progenitors differentiate toward neurons on soft matrices and on rigid ones they acquire glial phenotype. In the kidney, as in other organs, injury and inflammation can induce expansion and solidification of the ECM through its cross-linking, thus leading to increased stem cell cycling and exhaustion of their pool and acquisition of pro-fibrotic phenotypic changes by their progeny (see schema in Figure 3 ). This scenario awaits thorough exploration.
Potential therapeutic strategies to restore competence of endogenous stem cells Based on the studies by Weissman's group, it is becoming clear that restitution of the lost adult tissues would require provision of all necessary types of stem cells representative of all components of the destroyed original. In the case of the kidney, that would translate into the need for epithelial, endothelial and mesenchymal progenitors. Considering the possible exhaustion of local stem cell pools in the course of a disease, strategies to replenish these pools by exogenous stem cells embedded in artificial matrices mimicking stem cell niches are being developed (rev. in: [40] ).
An alternative strategy of rejuvenating the existing pool of local stem cells is gaining recognition. mTOR inhibition using rapamycin is a powerful tool to prevent epithelial stem cell senescence induced by noxious stimuli [41] . This effect has been attributed at least in part to the induction of mitochondrial superoxide dismutase (MnSOD) and the resulting inhibition of oxidative stress.
Epigenetic reprogramming has emerged as a potentially promising tool to improve the regenerative capacity of stem cells. Gudas' group [42] showed that DNA methyltrasferase inhibitor 5-aza-2 0 -deoxycytidine and histone deacetylase inhibitor trichostatin A increased stem cell proliferation and improved regeneration of an amputated digit in the adult mouse.
Finally, taking into consideration that it is the combination of mechanical stress and TGF-β that leads to fibrotic changes, attempts to reduce the impact of altered mechanome on stem cell transformation should be fruitful in preventing and reversing fibrosis. In this context, ECM should be considered as a tunable substrate affecting the fate and proliferation of stem cells. 
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